myosin heavy chain IIA
Ch'ŏnan, South Korea. In Kidney Res Clin Pract, Mar 2015
MYH9-related disorder is an autosomal dominant disease caused by a mutation in the MYH9 gene, which encodes nonmuscle myosin heavy chain IIA (NMMHC-IIA).
Nonmuscle myosin-2: mix and match.
Hannover, Germany. In Cell Mol Life Sci, 2013
Members of the nonmuscle myosin-2 (NM-2) family of actin-based molecular motors catalyze the conversion of chemical energy into directed movement and force thereby acting as central regulatory components of the eukaryotic cytoskeleton.
Myosinopathies: pathology and mechanisms.
Göteborg, Sweden. In Acta Neuropathol, 2013
Dominant or recessive mutations affecting the type IIa MyHC (MYH2) are associated with early-onset myopathies with variable muscle weakness and ophthalmoplegia as a consistent finding.
Advances in the understanding of MYH9 disorders.
Nagoya, Japan. In Curr Opin Hematol, 2010
PURPOSE OF REVIEW: MYH9 disorders are autosomal dominant macrothrombocytopenias with leukocyte inclusion bodies caused by mutations in MYH9, the gene for the nonmuscle myosin heavy chain IIA.